330 related articles for article (PubMed ID: 31779673)
1. Osteogenic commitment of Wharton's jelly mesenchymal stromal cells: mechanisms and implications for bioprocess development and clinical application.
Cabrera-Pérez R; Monguió-Tortajada M; Gámez-Valero A; Rojas-Márquez R; Borràs FE; Roura S; Vives J
Stem Cell Res Ther; 2019 Nov; 10(1):356. PubMed ID: 31779673
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
[TBL] [Abstract][Full Text] [Related]
3. Human Wharton's jelly-derived mesenchymal stromal cells promote bone formation in immunodeficient mice when administered into a bone microenvironment.
Cabrera-Pérez R; Ràfols-Mitjans A; Roig-Molina Á; Beltramone S; Vives J; Batlle-Morera L
J Transl Med; 2023 Nov; 21(1):802. PubMed ID: 37950242
[TBL] [Abstract][Full Text] [Related]
4. Chondrogenic induction of mesenchymal stromal/stem cells from Wharton's jelly embedded in alginate hydrogel and without added growth factor: an alternative stem cell source for cartilage tissue engineering.
Reppel L; Schiavi J; Charif N; Leger L; Yu H; Pinzano A; Henrionnet C; Stoltz JF; Bensoussan D; Huselstein C
Stem Cell Res Ther; 2015 Dec; 6():260. PubMed ID: 26718750
[TBL] [Abstract][Full Text] [Related]
5. Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells.
Donders R; Bogie JFJ; Ravanidis S; Gervois P; Vanheusden M; Marée R; Schrynemackers M; Smeets HJM; Pinxteren J; Gijbels K; Walbers S; Mays RW; Deans R; Van Den Bosch L; Stinissen P; Lambrichts I; Gyselaers W; Hellings N
Stem Cells Dev; 2018 Jan; 27(2):65-84. PubMed ID: 29267140
[TBL] [Abstract][Full Text] [Related]
6. Hypoxic culture conditions for Mesenchymal Stromal/Stem Cells from Wharton's jelly: a critical parameter to consider in a therapeutic context.
Reppel L; Margossian T; Yaghi L; Moreau P; Mercier N; Leger L; Hupont S; Stoltz JF; Bensoussan D; Huselstein C
Curr Stem Cell Res Ther; 2014; 9(4):306-18. PubMed ID: 24524785
[TBL] [Abstract][Full Text] [Related]
7. Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin.
Raicevic G; Najar M; Pieters K; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Tissue Eng Part A; 2012 Jul; 18(13-14):1410-8. PubMed ID: 22429150
[TBL] [Abstract][Full Text] [Related]
8. Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord.
Hsieh JY; Fu YS; Chang SJ; Tsuang YH; Wang HW
Stem Cells Dev; 2010 Dec; 19(12):1895-910. PubMed ID: 20367285
[TBL] [Abstract][Full Text] [Related]
9. Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells.
Datta I; Mishra S; Mohanty L; Pulikkot S; Joshi PG
Cytotherapy; 2011 Sep; 13(8):918-32. PubMed ID: 21696238
[TBL] [Abstract][Full Text] [Related]
10. Comparative Proteomic Analysis of the Mesenchymal Stem Cells Secretome from Adipose, Bone Marrow, Placenta and Wharton's Jelly.
Shin S; Lee J; Kwon Y; Park KS; Jeong JH; Choi SJ; Bang SI; Chang JW; Lee C
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467726
[TBL] [Abstract][Full Text] [Related]
11. Direct Comparison of Wharton's Jelly and Bone Marrow-Derived Mesenchymal Stromal Cells to Enhance Engraftment of Cord Blood CD34(+) Transplants.
van der Garde M; van Pel M; Millán Rivero JE; de Graaf-Dijkstra A; Slot MC; Kleinveld Y; Watt SM; Roelofs H; Zwaginga JJ
Stem Cells Dev; 2015 Nov; 24(22):2649-59. PubMed ID: 26414086
[TBL] [Abstract][Full Text] [Related]
12. Enhanced neuro-therapeutic potential of Wharton's Jelly-derived mesenchymal stem cells in comparison with bone marrow mesenchymal stem cells culture.
Drela K; Lech W; Figiel-Dabrowska A; Zychowicz M; Mikula M; Sarnowska A; Domanska-Janik K
Cytotherapy; 2016 Apr; 18(4):497-509. PubMed ID: 26971678
[TBL] [Abstract][Full Text] [Related]
13. Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells.
Balasubramanian S; Venugopal P; Sundarraj S; Zakaria Z; Majumdar AS; Ta M
Cytotherapy; 2012 Jan; 14(1):26-33. PubMed ID: 22091833
[TBL] [Abstract][Full Text] [Related]
14. Osteogenic differentiation of human mesenchymal stem cells from adipose tissue and Wharton's jelly of the umbilical cord.
Zajdel A; Kałucka M; Kokoszka-Mikołaj E; Wilczok A
Acta Biochim Pol; 2017; 64(2):365-369. PubMed ID: 28600911
[TBL] [Abstract][Full Text] [Related]
15. Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's jelly.
Amable PR; Teixeira MV; Carias RB; Granjeiro JM; Borojevic R
Stem Cell Res Ther; 2014 Apr; 5(2):53. PubMed ID: 24739658
[TBL] [Abstract][Full Text] [Related]
16. New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity.
Anzalone R; Lo Iacono M; Corrao S; Magno F; Loria T; Cappello F; Zummo G; Farina F; La Rocca G
Stem Cells Dev; 2010 Apr; 19(4):423-38. PubMed ID: 19958166
[TBL] [Abstract][Full Text] [Related]
17. Osteogenic differentiation of Wharton's jelly-derived mesenchymal stem cells cultured on WJ-scaffold through conventional signalling mechanism.
Beiki B; Zeynali B; Taghiabadi E; Seyedjafari E; Kehtari M
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S1032-S1042. PubMed ID: 30449193
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.
Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z
Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552
[TBL] [Abstract][Full Text] [Related]
19. An
Aslam N; Abusharieh E; Abuarqoub D; Alhattab D; Jafar H; Alshaer W; Masad RJ; Awidi AS
Pathol Oncol Res; 2021; 27():584710. PubMed ID: 34257532
[TBL] [Abstract][Full Text] [Related]
20. Netrin-1 acts as a non-canonical angiogenic factor produced by human Wharton's jelly mesenchymal stem cells (WJ-MSC).
Prieto CP; Ortiz MC; Villanueva A; Villarroel C; Edwards SS; Elliott M; Lattus J; Aedo S; Meza D; Lois P; Palma V
Stem Cell Res Ther; 2017 Feb; 8(1):43. PubMed ID: 28241866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
